These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7466015)

  • 1. [Endocavitary study of Lorcainide (author's transl)].
    Depaepe A; Sartieaux A; De Mey D
    Rev Med Brux; 1980 Mar; 1(3):157-9. PubMed ID: 7466015
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug.
    Solti F; Czakó E; Szatmáry L
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):26-9. PubMed ID: 3957486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P; Atallah G; Kirkorian G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 5. Lorcainide (R 15 889), a first review.
    Amery WK; Heykants JJ; Xhonneux R; Towse G; Oettel P; Gough DA; Janssen PA
    Acta Cardiol; 1981; 36(3):207-34. PubMed ID: 7020313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation.
    Bär FW; Farré J; Ross D; Vanagt EJ; Gorgels AP; Wellens HJ
    Br Heart J; 1981 Mar; 45(3):292-8. PubMed ID: 7470342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative electrophysiology of lorcainide and norlorcainide in the dog.
    Keefe DL; Kates RE; Winkle RA
    J Cardiovasc Pharmacol; 1984; 6(5):808-15. PubMed ID: 6209484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic effects of toxic concentrations of the antiarrhythmic drug lorcainide on the isolated canine ventricle.
    Senges J; Rizos I; Brachmann J; Gao TL; Lengfelder W; Kübler W
    J Pharmacol Exp Ther; 1982 Nov; 223(2):547-51. PubMed ID: 7131303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiological survey of antiarrhythmia in humans (author's transl)].
    Puech P
    Ann Cardiol Angeiol (Paris); 1977; 26(1):41-51. PubMed ID: 855988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of paroxysmal supraventricular tachycardia (author's transl)].
    González R
    Rev Med Chil; 1981 Mar; 109(3):246-51. PubMed ID: 7280410
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology of anti-arrhythmic agents (author's transl)].
    Hergueta G
    Folia Clin Int (Barc); 1975 Dec; 25(12):661-73. PubMed ID: 1220986
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological effects of lorcainide in sinoatrial disease and in Wolff-Parkinson-White syndrome.
    Manz M; Steinbeck G; Lüderitz B
    Eur Heart J; 1982 Feb; 3(1):56-66. PubMed ID: 7075612
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic reactions after intravenous injection of lorcainide hydrochloride in acute myocardial infarction.
    Shita A; Bernard R; Mostinckx R; Debacker M
    Eur J Cardiol; 1981; 12(5):237-42. PubMed ID: 7250167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of lorcainide.
    Keefe DL
    Am J Cardiol; 1984 Aug; 54(4):18B-21B. PubMed ID: 6465043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of magnesium sulphate on the supernormal phase of myocardial excitability (author's transl)].
    Critelli G; Maione S; Adinolfi L; Ferro G; Perticone F; Condorelli M
    Ann Cardiol Angeiol (Paris); 1977 Oct; 26(5):407-11. PubMed ID: 907304
    [No Abstract]   [Full Text] [Related]  

  • 17. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison in vitro of the electrophysiological effects of lorcainide and its metabolite norlorcainide.
    Carmeliet E
    Eur J Pharmacol; 1987 Jan; 133(1):29-36. PubMed ID: 3556390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical indications of different drugs for refractory arrhythmias (author's transl)].
    Leclercq JF; Coumel P
    Ther Umsch; 1982 Feb; 39(2):128-36. PubMed ID: 7071785
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic information required for design of programmed electrical stimulation protocols.
    Roden DM
    Circulation; 1986 Feb; 73(2 Pt 2):II39-44. PubMed ID: 3080263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.